Mutual Advisors LLC Makes New $314,000 Investment in Axon Enterprise, Inc $AXON

Mutual Advisors LLC bought a new position in shares of Axon Enterprise, Inc (NASDAQ:AXON) during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 379 shares of the biotechnology company’s stock, valued at approximately $314,000.

Other institutional investors have also made changes to their positions in the company. Jennison Associates LLC increased its stake in Axon Enterprise by 23,203.7% during the 1st quarter. Jennison Associates LLC now owns 614,053 shares of the biotechnology company’s stock worth $322,961,000 after acquiring an additional 611,418 shares during the period. Nuveen LLC acquired a new stake in shares of Axon Enterprise during the 1st quarter worth $264,796,000. McElhenny Sheffield Capital Management LLC bought a new position in shares of Axon Enterprise in the second quarter worth $255,833,000. Westfield Capital Management Co. LP raised its stake in Axon Enterprise by 29.8% in the first quarter. Westfield Capital Management Co. LP now owns 927,801 shares of the biotechnology company’s stock valued at $487,977,000 after purchasing an additional 212,931 shares in the last quarter. Finally, Vanguard Group Inc. raised its stake in Axon Enterprise by 2.2% in the first quarter. Vanguard Group Inc. now owns 8,632,008 shares of the biotechnology company’s stock valued at $4,540,005,000 after purchasing an additional 185,571 shares in the last quarter. 79.08% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several equities analysts have commented on AXON shares. Weiss Ratings reissued a “hold (c)” rating on shares of Axon Enterprise in a report on Wednesday, October 8th. Raymond James Financial reiterated an “outperform” rating and set a $855.00 price target (up previously from $645.00) on shares of Axon Enterprise in a research report on Tuesday, August 5th. JMP Securities restated a “market outperform” rating and set a $825.00 price objective on shares of Axon Enterprise in a research report on Monday, September 29th. Morgan Stanley set a $885.00 target price on Axon Enterprise and gave the stock an “overweight” rating in a research note on Friday, July 11th. Finally, Northland Securities set a $800.00 price target on Axon Enterprise in a research note on Tuesday, August 5th. Fourteen equities research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, Axon Enterprise currently has an average rating of “Moderate Buy” and an average price target of $841.64.

Insiders Place Their Bets

In other news, CFO Brittany Bagley sold 5,000 shares of the company’s stock in a transaction that occurred on Monday, September 29th. The stock was sold at an average price of $713.88, for a total value of $3,569,400.00. Following the completion of the transaction, the chief financial officer owned 93,592 shares of the company’s stock, valued at $66,813,456.96. This represents a 5.07% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, President Joshua Isner sold 15,919 shares of the firm’s stock in a transaction that occurred on Friday, August 15th. The shares were sold at an average price of $746.26, for a total transaction of $11,879,712.94. Following the completion of the transaction, the president owned 238,379 shares of the company’s stock, valued at approximately $177,892,712.54. This trade represents a 6.26% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 59,932 shares of company stock worth $45,115,616. Company insiders own 5.70% of the company’s stock.

Axon Enterprise Price Performance

AXON stock opened at $683.13 on Tuesday. Axon Enterprise, Inc has a 1 year low of $422.38 and a 1 year high of $885.91. The company has a debt-to-equity ratio of 0.63, a current ratio of 2.95 and a quick ratio of 2.71. The stock has a market cap of $53.63 billion, a price-to-earnings ratio of 168.67, a P/E/G ratio of 26.04 and a beta of 1.41. The company has a 50 day simple moving average of $736.73 and a 200 day simple moving average of $720.91.

Axon Enterprise (NASDAQ:AXON) last posted its earnings results on Monday, August 4th. The biotechnology company reported $2.12 earnings per share for the quarter, topping analysts’ consensus estimates of $1.54 by $0.58. The firm had revenue of $668.54 million for the quarter, compared to analysts’ expectations of $641.77 million. Axon Enterprise had a net margin of 13.64% and a return on equity of 6.80%. The company’s revenue was up 32.6% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.20 earnings per share. Axon Enterprise has set its FY 2025 guidance at EPS. Research analysts anticipate that Axon Enterprise, Inc will post 5.8 EPS for the current fiscal year.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.